Ekso Bionics Holdings Stock Analysis

Ekso Stock Analysis Notes

About 16.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.92. Some equities with similar Price to Book (P/B) outperform the market in the long run. Ekso Bionics Holdings recorded a loss per share of 0.56. The entity last dividend was issued on the 25th of March 2020. The firm had 1:15 split on the 25th of March 2020. Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company was incorporated in 2005 and is headquartered in Richmond, California. Ekso Bionics operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 55 people. To learn more about Ekso Bionics Holdings call the company at 510 984 1761 or check out https://www.eksobionics.com.

Ekso Bionics Holdings Investment Alerts

Ekso Bionics Holdings Upcoming and Recent Events

Ekso Largest EPS Surprises

View All Earnings Estimates

Ekso Bionics Thematic Classifications

Ekso Stock Institutional Investors

Note, although Ekso Bionics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Ekso Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 12.14 M.

Ekso Profitablity

The company has Profit Margin (PM) of (0.63) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.44) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.44.

Management Efficiency

Ekso Bionics Holdings has return on total asset (ROA) of (0.2353) % which means that it has lost $0.2353 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8952) %, meaning that it created substantial loss on money invested by shareholders. Ekso Bionics' management efficiency ratios could be used to measure how well Ekso Bionics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 25th of March 2025, Return On Tangible Assets is likely to drop to -0.55. In addition to that, Return On Capital Employed is likely to drop to -0.57. At this time, Ekso Bionics' Total Current Assets are very stable compared to the past year. As of the 25th of March 2025, Non Currrent Assets Other is likely to grow to about 489.9 K, while Total Assets are likely to drop about 26.2 M.

Technical Drivers

As of the 25th of March, Ekso Bionics shows the Standard Deviation of 6.5, variance of 42.28, and Mean Deviation of 4.85. Ekso Bionics Holdings technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Ekso Bionics Holdings Price Movement Analysis

Ekso Bionics Holdings Insider Trading Activities

Ekso Bionics Outstanding Bonds

Ekso Bionics Predictive Daily Indicators

Ekso Bionics Forecast Models

Ekso Bionics' time-series forecasting models are one of many Ekso Bionics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ekso Bionics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Ekso Bionics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Ekso shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Ekso Bionics. By using and applying Ekso Stock analysis, traders can create a robust methodology for identifying Ekso entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Ekso analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Ekso analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Ekso Bionics Holdings stock analysis indicators help investors evaluate how Ekso Bionics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Ekso Bionics shares will generate the highest return on investment. By understating and applying Ekso Bionics stock analysis, traders can identify Ekso Bionics position entry and exit signals to maximize returns.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ekso Bionics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ekso Bionics. If investors know Ekso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ekso Bionics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Ekso Bionics Holdings is measured differently than its book value, which is the value of Ekso that is recorded on the company's balance sheet. Investors also form their own opinion of Ekso Bionics' value that differs from its market value or its book value, called intrinsic value, which is Ekso Bionics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ekso Bionics' market value can be influenced by many factors that don't directly affect Ekso Bionics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Ekso Bionics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ekso Bionics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ekso Bionics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.